Subscribe to RSS
DOI: 10.1055/a-0749-6655
Effect of Selenium Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis
Publication History
received 09 May 2018
accepted 11 September 2018
Publication Date:
12 October 2018 (online)
![](https://www.thieme-connect.de/media/hmr/201810/lookinside/thumbnails/2018-09-0308_10-1055-a-0749-6655-1.jpg)
Abstract
Selenium is an essential mineral that plays a key role in plenty of major metabolic processes. A growing body of literature has shown that selenium deficiency leads to an increase in plasma TC and TG levels. This study explores the effect of selenium supplementation on serum level of lipid profile [total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), very low density lipoprotein (VLDL)]. We systematically searched PubMed/MEDLINE, ISI/WOS, and Scopus (from their commencements to Jan 2016) to identify the papers investigating the association between the intake of selenium and lipid profile. Data extracted from the relevant studies were screened. The pooled standardized mean difference was estimated using the random or fixed effects model. Heterogeneity among the studies was assessed using Q-test. Of the potentially relevant articles screened, 11 articles including 1221 participants were included in this meta-analysis. Results of meta-analysis showed that intake of selenium resulted in a statistically significant improvement in TC, [(SMD): –0.13, 95% CI: (–0.24, –0.02)], TG [(SMD): –0.19, 95% CI: (–0.38, –0.01)] and VLDL [(SMD): –0.34, 95% CI: (–0.63, –0.05)]. The selenium supplementation did not significantly improve lipid profile such as LDL [(SMD): –0.08, 95% CI: (–0.036, 0.19)], HDL [(SMD): 0.01, 95% CI: (–0.164, 0.18)], HDL/TC ratio [(SMD): 0.025, 95% CI: (–0.11, 0.16)], non-HDL-C [(SMD): 0.018, 95% CI: (–0.13, 0.16)]. This meta-analysis suggests that the effect of selenium supplementation on the serum levels of TG and VLDL is marginally significant. However, the supplementation has no effect on other serum lipids. Moreover, the study shows that the effect of selenium supplementation on lipid profile is negative.
-
References
- 1 Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: What is new?. Curr Opin Lipidol 2008; 19: 43-49
- 2 Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care 2002; 5: 75-79
- 3 Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid Redox Signal 2007; 9: 775-806
- 4 Dhingra S, Bansal M. Hypercholesterolemia and LDL receptor mRNA expression: Modulation by selenium supplementation. Biometals 2006; 19: 493-501
- 5 Dhingra S, Bansal M. Attenuation of LDL receptor gene expression by selenium deficiency during hypercholesterolemia. Mol Cell Biochem 2006; 282: 75-82
- 6 Dhingra S, Bansal M. Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation. Chem Biol Interact 2006; 161: 49-56
- 7 Sengupta A, Carlson BA, Hoffmann VJ, Gladyshev VN, Hatfield DL. Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem Biophys Res Commun 2008; 365: 446-452
- 8 Benstoem C, Goetzenich A, Kraemer S, Borosch S, Manzanares W, Hardy G, Stoppe C. Selenium and its supplementation in cardiovascular disease—what do we know?. Nutrients 2015; 7: 3094-3118
- 9 Huang K, Liu H, Chen Z, Xu H. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 2002; 162: 137-144
- 10 Lee O, Moon J, Chung Y. The relationship between serum selenium levels and lipid profiles in adult women. J Nutr Sci Vitaminol 2003; 49: 397-404
- 11 Wojcicki J, Różewicka L, Barcew-Wiszniewska B, Samochowiec L, Juiwiak S, Kadłubowska D, Tustanowski S, Juzyszyn Z. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991; 87: 9-16
- 12 Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC. Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab (Lond) 2010; 7: 38
- 13 Jossa F, Trevisan M, Krogh V, Farinaro E, Giumetti D, Fusco G, Galasso R, Panico S, Frascatore S, Mellone C. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991; 87: 129-134
- 14 Bleys J, Navas-Acien A, Stranges S, Menke A, Miller 3rd ER, Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr 2008; 88: 416-423
- 15 Hercberg S, Bertrais S, Czernichow S, Noisette N, Galan P, Jaouen A, Tichet J, Briancon S, Favier A, Mennen L, Roussel AM. Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study. Lipids 2005; 40: 335-342
- 16 Rayman MP, Stranges S, Griffin BA, Pastor-Barriuso R, Guallar E. Effect of supplementation with high-selenium yeast on plasma lipids: A randomized trial. Ann Intern Med 2011; 154: 656-665
- 17 Tabrizi R, Akbari M, Moosazadeh M, Lankarani KB, Heydari ST, Kolahdooz F, Mohammadi AA, Shabani A, Badehnoosh B, Jamilian M, Assarian A, Asemi Z. The effects of selenium supplementation on glucose metabolism and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Horm Metab Res 2017; 49: 826-830
- 18 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6: e1000097
- 19 Nikuei P, Davoodian N, Tahamtan I, Keshtkar A. Predictive value of miR-210 as a novel biomarker for pre-eclampsia: A systematic review protocol. BMJ Open 2016; 6: e011920
- 20 Djalalinia S, Khosravi M, Hasani M, Saeedi Moghaddam S, Kazemzadeh Atoofi M, Asayesh H, Mahdavi-Gorabi A, Soleimani A, Qorbani M. Effects of Selenium supplementation on cardiometabolic risk factors, inflammatory factors and antioxidant factors : a systematic review and meta-analysis protocol. IJPM 2017 submitted
- 21 Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
- 22 DeSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
- 23 Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-1677
- 24 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
- 25 StataCorp . Stata Statistical Software: Release 10. 2007. College Station, TX: StataCorp LP;
- 26 Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A. Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes:Randomized, double-blind, placebo-controlled trial. Nutrition 2015; 31: 1235-1242
- 27 Shargorodsky M, Debby O, Matas Z, Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab 2010; 7: 55
- 28 Alizadeh M, Safaeiyan A, Ostadrahimi A, Estakhri R, Daneghian S, Ghaffari A, Pourghassem BG. Effect of L-Arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab 2012; 60: 157-168
- 29 Madaric A, Kadrabova J, Krajcovicova-Kudlackova M, Valachovicova M, Spustova V, Mislanova C, Kajaba I, Blazicek P. The effect of bioactive complex of quercetin, selenium, catechins and curcumin on cardiovascular risk markers in healthy population after a two month consumption. Bratisl Lek Listy 2013; 114: 84-87
- 30 Ravn-Haren G, Bügel S, Krath BN, Hoac T, Stagsted J, Jørgensen K, Bresson JR, Larsen EH, Dragsted LO. Dragsted. A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: Effects on oxidative defence regulation. Br J Nutr 2008; 99: 883-892
- 31 Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, Taylor AW, Traber MG, Zimmermann MB. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J. Nutr 2014; 144: 193-201
- 32 Jamilian M, Razavi M, Kashan ZF, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clin Endocrinol 2015; 82: 885-891
- 33 Faghihi T, Radfar M, Barmal M, Amini P, Qorbani M, Abdollahi M, Larijani B. A Randomized, Placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: effects on glucose homeostasis, oxidative stress, and lipid profile. Am J Ther 2014; 21: 491-495
- 34 Farrokhian F, Bahmani M, Taghizadeh SM, Mirhashemi MH, Aarabi F, Raygan E, Aghadavod Z, Asemi Z. Selenium supplementation affects insulin resistance and serum hs-crp in patients with type 2 diabetes and coronary heart disease. Horm Metab Res 2016; 48: 263-268
- 35 Bahmani F, Kia M, Soleimani A, Asemi Z, Esmaillzadeh A. Effect of Selenium supplementation on glycemic control and lipid profiles in patients with diabetic nephropathy. Biol Trace Elem Res 2016; 172: 282-289
- 36 Cold F, Winther KH, Pastor-Barriuso R, Rayman MP, Guallar E, Nybo M, Griffin BA, Stranges S, Cold S. Randomised controlled trial of the effect of long-term selenium supplementation on plasma cholesterol in an elderly Danish population. Br J Nutr 2015; 114: 1807-1818
- 37 Chen C, Jin Y, Unverzagt FW, Cheng Y, Hake AM, Liang C, Ma F, Su L, Liu J, Bian J, Li P, Gao S. The association between selenium and lipid levels: A longitudinal study in rural elderly Chinese. Arch Gerontol Geriatr 2015; 60: 147-152
- 38 Rayman MP, Stranges S, Griffin BA, Pastor-Barriuso R, Guallar E. Effect of supplementation with high-selenium yeast on plasma lipids: A randomized trial. Ann Intern Med 2011; 154: 656-665
- 39 Faghihi T, Radfar M, Barmal M, Amini P, Qorbani M, Abdollahi M, Larijani B. A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: Effects on glucose homeostasis, oxidative stress, and lipid profile. Am J Ther 2014; 21: 491-495
- 40 Stranges S, Laclaustra M, Ji C, Cappuccio FP, Navas-Acien A, Ordovas JM, Rayman M, Guallar E. Higher selenium status is associated with adverse blood lipid profile in british adults. J Nutr 2010; 140: 81-87
- 41 Ju W, Ji M, Li X, Li Z, Wu G, Fu X, Yang X, Gao X. Relationship between higher serum selenium level and adverse blood lipid profile. Clin Nutr 2017; pii: S0261-5614(17)30308-4. DOI: 10.1016/j.clnu.2017.08.025. [Epub ahead of print]
- 42 Omrani H, Golmohamadi S, Pasdar Y, Jasemi K, Almasi A. Effect of selenium supplementation on lipid profile in hemodialysis patients. J Renal Inj Prev 2016; 5: 179-182
- 43 Bleys J, Navas-Acien A, Stranges S, Menke A, Miller 3rd ER, Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr 2008; 88: 416-423
- 44 Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-241